A Study of 177Lu-DTPA-Omburtamab in Children and Adolescents With Brain Cancer or Cancer That Has Spread to the Central Nervous System (CNS)
Conditions
Recurrent Medulloblastoma · Refractory Medulloblastoma · CNS Metastases · Central Nervous System Metastasis
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Memorial Sloan Kettering Cancer Center Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States
Memorial Sloan Kettering at Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States
Memorial Sloan Kettering at Bergen (Limited Protocol Activities), Montvale, New Jersey, United States
Memorial Sloan Kettering at Suffolk-Commack (Limited Protocol Activities), Commack, New York, United States
Memorial Sloan Kettering at Westchester (Limited Protocol Activities), Harrison, New York, United States
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States
Memorial Sloan Kettering at Nassau (Limited Protocol Activities), Uniondale, New York, United States
Study leads
Sameer Farouk Sait, MBBS
Principal Investigator
Memorial Sloan Kettering Cancer Center